To determine the stability of MYC in CRC cell lines dependent on CIP2A, we treated cells with cycloheximide to inhibit new protein synthesis and measured the amount of remaining MYC protein by immunoblotting at several time points after treatment (Fig. 2a–c). This evidence concerns the gene CIP2A and colorectal carcinoma.